期刊文献+

新疆乌鲁木齐汉族、维族骨量减少女性骨生化标志物和维生素D水平的研究 被引量:1

Study of bone biochemical markers and vitamin D level in Han and Uygur women with osteopenia in Urumqi
下载PDF
导出
摘要 目的通过分析新疆乌鲁木齐地区汉族与维吾尔族骨量减少女性之间骨生化标志物和维生素D的水平,探讨维吾尔族骨量减少的特点。方法选择2008年5月至2011年3月期间,我院就诊的骨量减少的女性500例,其中汉族306例(61.2%),维族194例(38.8%),对比分析两组体重指数、血清电解质、部分骨生化标记物以及25羟基维生素D水平。结果两组平均年龄、体重指数、血清Ca、P、Mg水平无统计学差异(P>0.05);骨特异性碱性磷酸酶(BAP)无显著性差异(P>0.05);骨钙素(BGP)、抗酒石酸酸性磷酸酶5b(TRACP-5b)水平,维吾尔族高于汉族组(P<0.05);汉族各年龄阶段VitD水平均高于维吾尔族,具有统计学显著性差异。结论骨转换水平较高和VitD缺乏在维吾尔族女性骨量减少中发挥着重要的作用。 Objective To study the characteristic of Uygur women with osteopenia by analyzing the biochemical markers of bone turnover and vitamin D between Uygur and Han in Urumqi. Methods Five hundred women who were diagnosed as osteopenia in our hospital from May 2008 to Mar 2011 were included in this study. Among those, 306 women were Han and 194 were Uygur. Body mass index (BMI) , serum electrolytes, bone biochemical markers, and 25-hydroxy vitamin D were analyzed and compared between Han and Uygur groups. Results There were no significant differences in BMI, serum Ca, P, Mg levels, and bone specific alkaline phosphatase (BAP) between the two groups (P 〉 0.05 ). The levels of bone gamma- carboxyglutamieacid-containing proteins (BGP) and tartrate-resistant acid phosphatase 5b (TRACP-5b) in Uygur patients were significantly higher than those in Han patients ( P 〈 0.05 ). The level of 25-hydroxy vitamin D (25-(OH)-Vit D) in Han group was significant higher than that in Uygur group (P 〈 0.05 ). Conclusion High level of bone turnover and 25 - (OH) - Vit D deficiency plays an important role in the process of osteopenia in Uygur women.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第9期785-787,共3页 Chinese Journal of Osteoporosis
关键词 骨量减少 骨转换生化标志物 25羟基维生素D Osteopenia Biochemical marker 25-hydroxy vitamin D
  • 相关文献

参考文献10

  • 1Ivaska KK, Gerdhem P, Vaananen HK, et al, Bone Turnover Markers and Prediction of Fracture: A Prospeetive Follow-up Study of 1040 Elderly Women for a Mean of Nine Years. J Bone Miner Res, 2010, 25(2) : 393-403.
  • 2Delmas P, Watts N, Miller P, et al. Bone turnover markers demonstrate greater earlier responsiveness to teriparatide following treatment with risedronate compared with alendronate : The OPTAMISE Study. J Bone Miner Res, 2007, 22 (suppl 1 ): S27.
  • 3Shidara K, Inaba M. Bone metabolic marker for osteoporosis. Nippon Rinsho, 2009, 67 (5) : 927-931.
  • 4Kazutoshi N. Vitamin D insufficiency in Japanese populations: from the viewpoint of the prevention of osteoporosis. J Bone Miner Metab, 2006, 24(1): 1-6.
  • 5Nakamura K, Ueno K, Nishiwaki T, et al. Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr,2005, 82(5) :1127-1133.
  • 6Nakamura K, Nashimoto M, Hori Y, et al. Serum 25-hydroxy vitamin D concentrations and related dietary factors in peri- and postmenopausal Japanese women. Am J Clin Nutr, 2000, 71 (5) :1161-1165.
  • 7林海丹,罗庆禄,何成奇,杨霖,何红晨,伍援朝,蓝群,谢薇,熊恩富.男性骨量减少者与骨质疏松者的体重指数与腰椎平均骨密度的相关性研究[J].生物医学工程学杂志,2010,27(1):138-141. 被引量:5
  • 8胡伟伟,张浩,顾洁梅,黄琪仁,陆敬辉,刘玉娟,胡云秋,李淼,章振林.阿仑膦酸钠对绝经后骨质疏松或骨量减少妇女骨密度影响的研究[J].中国全科医学,2010,13(3):225-227. 被引量:32
  • 9Majima T, Shimatsu A, Komatsu Y, et al. Increased bone turnover in patients with hypercholesterolemia. Endocr J,2008, 55(1) :143-151.
  • 10Nenonen A. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res, 2005,20(10) :1804-1812.

二级参考文献27

共引文献34

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部